bell
The current prices are delayed by 15 mins, login to check live prices.
Syngene International Ltd share price logo

Syngene International Ltd Share Price

(SYNGENE)

₹819.55▲0.32%

as on 04:01PM, 17 Jan 2025

Option Chain

Overview
News
Financials
Q3 2024 Results
Technicals
F&O

Syngene International Ltd Analyst Rating

based on 8 analysts

HOLD

50.00%

Buy

12.50%

Hold

37.50%

Sell

Based on 8 analysts offering long term price targets for Syngene International Ltd. An average target of ₹893.75

Source: S&P Global Market Intelligence

Syngene International Ltd Share analysis

Syngene International Ltd price forecast by 8 analysts

Upside of9.05%

High

₹1100

Target

₹893.75

Low

₹700

Syngene International Ltd target price ₹893.75, a slight upside of 9.05% compared to current price of ₹819.55. According to 8 analysts rating.

Source: S&P Global Market Intelligence

Syngene International Ltd Performance

  • Day's Low

    Day's High

    ₹810.5
    Day's Price Range
    ₹823.55

  • 52 Week's Low

    52 Week's High

    ₹607.65
    52-Week Price Range
    ₹960.6
1 Month Return-4.64 %
3 Month Return-6.59 %
1 Year Return+ 17.64 %
Previous Close₹816.95
Open₹816.95
Volume1.82L
Upper Circuit-
Lower Circuit-
Market Cap₹32,885.26Cr

Syngene International Ltd Key Statistics

P/E Ratio68.24
PEG Ratio-213.25
Market Cap₹32,885.26 Cr
P/B Ratio6.73
EPS12.69
Dividend Yield0.18
SectorHealthcare
ROE11.95

Syngene International Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Syngene International Ltd
Syngene International Ltd
HOLD₹32,885.26 Cr32.98%0.56₹510 Cr₹3,488 Cr
Sanofi India Ltd
Sanofi India Ltd
BUY₹12,534.65 Cr-3.67%0.52₹602 Cr₹2,851 Cr
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
BUY₹67,752.08 Cr28.8%0.56₹3,168 Cr₹29,001 Cr
Zydus Lifesciences Ltd
Zydus Lifesciences Ltd
HOLD₹99,431.01 Cr54.52%0.64₹3,854 Cr₹19,547 Cr
Abbott India Ltd
Abbott India Ltd
BUY₹58,008.46 Cr24.18%0.53NANA
See all

Syngene International Ltd Mutual Fund Holdings

About Syngene International Ltd

Syngene International Limited is a India-based research, development, and manufacturing services organization driven by a team of 5200 scientists. It focuses primarily on the pharmaceutical and biotechnology sectors, and also provides services for nutrition, animal health, consumer goods, and other chemical sectors. The company’s health-related services extends across all major therapy areas and modalities. The operations are spread across 2 million sq. ft. with facilities at Bangalore, Hyderabad, and Mangalore. Syngene International Limited was incorporated in 1993 and consistently has entered into partnerships for research and development. This helped Syngene International cross an annual turnover of Rs 1000 crore in the year 2016. Over the years leading up to 2021, Syngene International expanded its research collaboration with companies such as Abbott, Bristol Myers Squibb, Herbalife, and Glaxo Smith Kline. It also commissioned new facilities and added bioreactors and microbial manufacturing capacity to strengthen biologics manufacturing. With investments in R&D and strengthening scientific capabilities, Syngene International continues to provide integrated drug discovery services.

Share Price: ₹819.55 per share as on 17 Jan, 2025 04:01 PM
Market Capitalisation: ₹32,885.26Cr as of today
Revenue: ₹891.00Cr as on September 2024 (Q3 24)
Net Profit: ₹106.10Cr as on September 2024 (Q3 24)
Listing date: 11 Aug, 2015
Chairperson Name: Kiran Mazumdar Shaw
OrganisationSyngene International Ltd
Headquarters
IndustryHealthcare
E-voting on sharesClick here to vote

Key events for Syngene International Ltd

  • Syngene Rating Upgraded with Higher Target Price - 10 Jan, 2025

    Jefferies has upgraded Syngene International Ltd's rating to Hold, increasing the target price to ₹890 from ₹740, reflecting positive market sentiment.

  • Syngene International's CSR Investment Highlights - 31 Dec, 2024

    Biocon Limited and its subsidiaries, including Syngene International, invested Rs. 31.54 crore in CSR initiatives for FY 2023-24, benefiting over 3.75 lakh individuals across various sectors.

  • Biocon Reduces Stake in Syngene Through Sale - 13 Dec, 2024

    Biocon announced the sale of 80 lakh equity shares of Syngene International, raising ₹686 crore and reducing its shareholding to 52.46%. Despite a slight decline, Syngene has increased investor wealth by 23% over the past year.

Insights on Syngene International Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 20.63% to 20.72% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 839.8 Cr → 907.5 Cr (in ₹), with an average increase of 7.5% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 75.7 Cr → 106.1 Cr (in ₹), with an average increase of 28.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vimta Labs Ltd has given 111.6% return, outperforming this stock by 99.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 54.72% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Shree Ganesh Remedies Ltd has given 129.0% return, outperforming this stock by 98.9%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 13.63% to 13.58% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SYNGENE stock has moved down by -4.2%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.42% to 6.74% in Sep 2024 quarter

Syngene International Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹910.10Cr (-)₹853.50Cr (↓6.22%)₹916.90Cr (↑7.43%)₹789.70Cr (↓13.87%)₹891.00Cr (↑12.83%)
Net Income₹116.50Cr (-)₹111.50Cr (↓4.29%)₹188.60Cr (↑69.15%)₹75.70Cr (↓59.86%)₹106.10Cr (↑40.16%)
Net Profit Margin12.80% (-)13.06% (↑2.03%)20.57% (↑57.50%)9.59% (↓53.38%)11.91% (↑24.19%)
Value in ₹ crore
Details2021202220232024
Total Assets₹4,977.30Cr (-)₹5,686.00Cr (↑14.24%)₹5,970.10Cr (↑5.00%)₹5,962.40Cr (↓0.13%)
Total Liabilities₹2,159.00Cr (-)₹2,394.00Cr (↑10.88%)₹2,351.20Cr (↓1.79%)₹1,770.90Cr (↓24.68%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹677.40Cr (-)₹698.00Cr (↑3.04%)₹582.20Cr (↓16.59%)₹838.40Cr (↑44.01%)₹913.40Cr (↑8.95%)

Index Inclusions

BSE Healthcare

₹42,660.26

0.22 (▲95.19%)

Nifty Healthcare

₹14,057.75

0.43 (▲60.65%)

Nifty 500

₹21,680.25

-0.16 (▲-34.3%)

Nifty Midcap 150

₹20,195.90

0.12 (▲23.25%)

S&P BSE 150 MidCap

₹15,138.10

0.09 (▲13.37%)

Nifty LargeMidcap 250

₹15,180.20

-0.07 (▲-10.05%)

BSE 500

₹34,083.34

-0.16 (▲-53.44%)

S&P BSE 400 MidSmallCap

₹11,515.38

0.04 (▲4.9%)

S&P BSE 250 LargeMidCap

₹10,088.08

-0.17 (▲-17.11%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

S&P BSE SmallCap Select

₹7,652.04

0.11 (▲8.62%)

Nifty MidSmallcap 400

₹18,978.85

0.06 (▲10.9%)

BSE Small-Cap

₹52,311.31

0.01 (▲2.64%)

Syngene International Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
54.72%
0.00
Foreign Institutions
20.72%
0.42
Mutual Funds
13.58%
-0.41
Retail Investors
6.74%
-9.19
Others
4.24%
18.11

Syngene International Ltd Key Indicators

Details20202021202220232024
Earning Per Share (₹)10.310.129.8811.5712.69
Details20202021202220232024
Return On Equity %17.2816.1712.8913.6911.95
Details20202021202220232024
Return On Assets %9.78.136.967.788.55
Details20202021202220232024
Book Value Per Share (₹)54.470.5482.2890.13105.92

Syngene International Ltd Valuation

Syngene International Ltd in the last 5 years

  • Overview

  • Trends

Lowest (23.09x)

March 31, 2020

Today (68.24x)

January 17, 2025

Industry (97.73x)

January 17, 2025

Highest (78.92x)

December 2, 2024

LowHigh

Syngene International Ltd Earnings and Dividends

  • Syngene International Ltd Earnings Results

    Syngene International Ltd’s net profit fell -8.93% since last year same period to ₹106.10Cr in the Q2 2024-2025. On a quarterly growth basis, Syngene International Ltd has generated 40.16% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Syngene International Ltd Dividends April,2024

    In the quarter ending March 2024, Syngene International Ltd has declared dividend of ₹1.25 - translating a dividend yield of 0.31%.

    Read More about Dividends

Syngene International Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Syngene International Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

FAQs on Syngene International Ltd

Syngene International Ltd share price today stands at ₹819.55, Open. ₹816.95 ; Previous Close. ₹816.95 ; High. ₹823.55 ; Low. ₹810.5 ; 52 Week High. ₹960.6 ; 52 Week Low: ₹607.65.

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Syngene International Ltd shares.

Syngene International Ltd is listed on NSE

Syngene International Ltd is listed on BSE

  • Today’s highest price of Syngene International Ltd is ₹823.55.
  • Today’s lowest price of Syngene International Ltd is ₹810.5.

PE Ratio of Syngene International Ltd is 68.24

PE ratio = Syngene International Ltd Market price per share / Syngene International Ltd Earnings per share

Today’s traded volume of Syngene International Ltd(SYNGENE) is 1.82L.

Today’s market capitalisation of Syngene International Ltd(SYNGENE) is ₹32885.26Cr.

Syngene International Ltd(SYNGENEPrice
52 Week High
₹960.6
52 Week Low
₹607.65

Syngene International Ltd(SYNGENE) share price is ₹819.55. It is down -14.68% from its 52 Week High price of ₹960.6

Syngene International Ltd(SYNGENE) share price is ₹819.55. It is up 34.87% from its 52 Week Low price of ₹607.65

Syngene International Ltd(SYNGENEReturns
1 Day Returns
2.6%
1 Month Returns
-4.64%
3 Month Returns
-6.59%
1 Year Returns
17.64%